Premium
This is an archive article published on January 17, 2011

Glenmark Pharma stock plummets 4%

Glenmark Pharmaceuticals stock was lower after it lost a patent case to Abbott Laboratories.

Shares of Glenmark Pharmaceuticals were lower on reports over the weekend that the company has lost a patent case against U.S. firm Abbott Laboratories over hypertension drug Tarka.

Subsequently,it will pay $16 million in damages to the U.S. firm,two dealers said.

At 9.25 a.m.,shares of the company were down 4.13 percent at 333.50 rupees.

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement